Longitudinally Profiling Neutralizing Antibody Response to SARS Coronavirus with Pseudotypes

Longitudinally Profiling Neutralizing Antibody Response to SARS Coronavirus with Pseudotypes

The severe acute respiratory syndrome–associated coronavirus (SARS-CoV) spike protein (S) is a major target for neutralizing antibodies. Retroviral SARS-CoV S pseudotypes have been constructed and used to develop an in vitro microneutralization assay that is both sensitive and specific for SARS-CoV...

Full description

Bibliographic Details
Main Authors: Nigel J. Temperton, Paul K. Chan, Graham Simmons, Maria C. Zambon, Richard S. Tedder, Yasuhiro Takeuchi, Robin A. Weiss
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2005-03-01
Series:Emerging Infectious Diseases
Subjects:
SARS virus
Neutralization tests
Infectious diseases
emerging
Vaccines
research
Online Access:https://wwwnc.cdc.gov/eid/article/11/3/04-0906_article

Internet

https://wwwnc.cdc.gov/eid/article/11/3/04-0906_article

Similar Items